PUBLISHER: TechNavio | PRODUCT CODE: 1723109
PUBLISHER: TechNavio | PRODUCT CODE: 1723109
The psychedelic drugs market is forecasted to grow by USD 1946.2 mn during 2024-2029, accelerating at a CAGR of 14.3% during the forecast period. The report on the psychedelic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of mental health disorders, increasing acceptance and legalization of psychedelic substances, and growing government programs and initiatives focused on mental health.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 12.2% |
CAGR | 14.3% |
Incremental Value | $1946.2 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's psychedelic drugs market is segmented as below:
By Type
By Distribution Channel
By Application
By Route Of Administration
By Geographical Landscape
This study identifies the increasing focus of companies on developing next-generation therapies for psychiatric disorders as one of the prime reasons driving the psychedelic drugs market growth during the next few years. Also, rising emphasis of companies on mergers and acquisitions and expanding therapeutic applications of psychedelics will lead to sizable demand in the market.
The report on the psychedelic drugs market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading psychedelic drugs market vendors that include AbbVie Inc., Avadel Pharmaceuticals plc, Braxia Scientific Corp., COMPASS Pathways plc, Cybin Inc., HAVN Life Sciences Inc, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lykos Therapeutics, Pfizer Inc., Seelos Therapeutics Inc., Silo Pharma Inc., and Stella Center. Also, the psychedelic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: